A Varegacestat Hepatic Impairment Study

NCT06841315 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer
Hepatic Impairment (HI)

Interventions

DRUG: varegacestat

Sponsor

Immunome, Inc.